A phase I-II study with intraperitoneal cisplatin plus systemic etoposide in patients with minimal residual ovarian cancer.
Willemse, P H
A phase I-II study with intraperitoneal cisplatin plus systemic etoposide in patients with minimal residual ovarian cancer. [electronic resource] - European journal of cancer (Oxford, England : 1990) 1992 - 479-81 p. digital
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
0959-8049
10.1016/s0959-8049(05)80081-4 doi
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Cisplatin--administration & dosage
Drug Evaluation
Etoposide--administration & dosage
Female
Humans
Infusions, Parenteral
Injections, Intravenous
Leukopenia--chemically induced
Middle Aged
Ovarian Neoplasms--drug therapy
A phase I-II study with intraperitoneal cisplatin plus systemic etoposide in patients with minimal residual ovarian cancer. [electronic resource] - European journal of cancer (Oxford, England : 1990) 1992 - 479-81 p. digital
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
0959-8049
10.1016/s0959-8049(05)80081-4 doi
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Cisplatin--administration & dosage
Drug Evaluation
Etoposide--administration & dosage
Female
Humans
Infusions, Parenteral
Injections, Intravenous
Leukopenia--chemically induced
Middle Aged
Ovarian Neoplasms--drug therapy